Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 04:00PM ET
13.17
Dollar change
+0.03
Percentage change
0.23
%
IndexRUT P/E- EPS (ttm)-3.12 Insider Own20.44% Shs Outstand68.39M Perf Week-8.41%
Market Cap992.23M Forward P/E- EPS next Y-2.61 Insider Trans-0.24% Shs Float59.94M Perf Month9.57%
Income-213.02M PEG- EPS next Q-0.74 Inst Own81.28% Short Float11.15% Perf Quarter22.85%
Sales0.00M P/S- EPS this Y11.58% Inst Trans-3.10% Short Ratio8.06 Perf Half Y136.87%
Book/sh5.58 P/B2.36 EPS next Y8.95% ROA-40.17% Short Interest6.68M Perf Year6.90%
Cash/sh5.73 P/C2.30 EPS next 5Y- ROE-50.32% 52W Range4.92 - 17.00 Perf YTD56.23%
Dividend Est.- P/FCF- EPS past 5Y-19.52% ROI-46.96% 52W High-22.53% Beta1.26
Dividend TTM- Quick Ratio10.11 Sales past 5Y0.00% Gross Margin- 52W Low167.68% ATR (14)0.99
Dividend Ex-Date- Current Ratio10.11 EPS Y/Y TTM2.71% Oper. Margin- RSI (14)54.59 Volatility6.20% 7.70%
Employees331 Debt/Eq0.20 Sales Y/Y TTM- Profit Margin- Recom1.11 Target Price17.00
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q25.12% Payout- Rel Volume1.05 Prev Close13.14
Sales Surprise- EPS Surprise17.41% Sales Q/Q- EarningsNov 12 BMO Avg Volume828.88K Price13.17
SMA205.15% SMA5010.06% SMA20040.69% Trades Volume873,887 Change0.23%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated ROTH MKM Buy $17
Apr-17-23Resumed Piper Sandler Overweight $44
Nov-19-21Initiated Piper Sandler Overweight $52
Oct-15-21Resumed BTIG Research Buy $60
Nov-17-20Initiated BTIG Research Buy $60
Nov-02-20Initiated Jefferies Buy $67
Oct-15-20Upgrade H.C. Wainwright Neutral → Buy $25 → $54
Jul-01-20Downgrade H.C. Wainwright Buy → Neutral $25
May-05-20Initiated Barclays Overweight $21
Sep-04-19Initiated ROTH Capital Buy $20
Nov-25-24 11:55PM
07:09AM
Nov-22-24 04:00PM
05:48AM
Nov-21-24 04:05PM
08:00AM Loading…
Nov-12-24 08:00AM
Nov-09-24 01:00PM
Nov-08-24 04:01PM
Oct-30-24 09:15AM
Oct-09-24 04:01PM
Oct-07-24 09:11PM
Oct-01-24 08:00AM
Sep-15-24 09:45AM
Sep-09-24 08:00AM
Sep-05-24 08:00AM
08:00AM Loading…
Aug-22-24 08:00AM
Aug-14-24 04:33PM
Aug-13-24 08:00AM
Aug-08-24 08:00AM
Jul-30-24 04:01PM
Jun-13-24 08:30AM
Jun-07-24 09:03AM
08:00AM
Jun-06-24 12:16PM
07:00AM
Jun-03-24 08:00AM
May-23-24 05:00PM
May-16-24 01:53PM
08:00AM
Apr-07-24 05:00PM
08:00AM Loading…
Apr-04-24 08:00AM
Mar-26-24 07:30AM
Mar-11-24 09:55AM
Mar-08-24 12:00PM
Mar-06-24 08:00AM
Mar-05-24 08:00AM
Feb-27-24 03:30AM
Feb-23-24 09:55AM
Feb-08-24 08:42AM
08:00AM
Jan-22-24 10:54AM
Jan-16-24 03:59AM
Dec-28-23 08:00AM
Dec-05-23 07:32AM
07:10AM
07:00AM
Nov-13-23 09:55AM
Nov-08-23 09:10AM
Nov-07-23 08:00AM
Nov-03-23 07:30PM
Oct-17-23 03:00AM
Sep-19-23 04:01PM
08:00AM
Sep-14-23 01:23PM
Aug-03-23 08:00AM
Aug-01-23 08:00AM
Jul-31-23 04:01PM
Jul-28-23 03:57PM
Jul-20-23 08:00AM
Jun-06-23 10:00AM
Jun-05-23 08:00AM
Jun-03-23 02:15PM
Jun-01-23 04:01PM
May-25-23 05:00PM
May-18-23 08:00AM
May-17-23 10:02AM
May-09-23 08:00AM
Mar-31-23 09:35AM
Mar-08-23 08:00AM
Feb-24-23 09:35AM
Feb-09-23 08:50AM
08:00AM
Feb-07-23 08:00AM
Jan-06-23 09:55AM
09:04AM
08:50AM
Jan-05-23 05:44AM
Jan-04-23 08:05AM
08:00AM
Jan-03-23 08:00AM
Dec-14-22 10:46AM
Dec-12-22 02:36PM
Dec-08-22 09:04PM
Dec-07-22 04:04PM
10:05AM
07:00AM
06:30AM
Nov-23-22 08:00AM
Nov-22-22 08:00AM
Nov-03-22 08:00AM
Nov-02-22 04:01PM
Oct-14-22 01:52PM
Oct-07-22 08:00AM
Aug-24-22 07:58AM
Aug-06-22 09:36AM
Aug-04-22 08:00AM
Aug-01-22 04:01PM
Jun-03-22 08:00AM
Jun-02-22 08:00AM
May-30-22 06:42AM
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xynos KonstantinosChief Medical OfficerNov 18 '24Sale10.787,24678,112109,885Nov 20 09:31 PM
Sarchi ChristopherChief Commercial OfficerNov 18 '24Sale10.785,20756,13187,045Nov 20 09:30 PM
Hill Emily LuisaChief Financial OfficerAug 16 '24Sale10.188,93890,989101,057Aug 19 08:00 PM
Xynos KonstantinosChief Medical OfficerJun 07 '24Sale7.5015,881119,108117,131Jun 10 08:30 PM
Sarchi ChristopherChief Commercial OfficerMay 16 '24Sale6.472,21814,35092,252May 20 08:06 PM
Schwendenman AndrewChief Accounting OfficerMay 16 '24Sale6.472,29814,86838,238May 20 08:06 PM
Love ColinChief Operating OfficerMay 16 '24Sale6.4717,615113,969777,345May 20 08:05 PM
Astley-Sparke PhilipExecutive ChairmanMay 16 '24Sale6.4737,928245,3941,487,350May 20 08:04 PM
Coffin RobertDirectorMay 16 '24Sale6.4711,46474,1721,821,872May 20 08:02 PM
Patel SushilChief Executive OfficerMay 16 '24Sale6.4720,194130,655212,014May 20 08:01 PM
Xynos KonstantinosChief Medical OfficerMay 16 '24Sale6.476,36741,194133,012May 20 08:00 PM